Trial Profile
A Phase I, Open-Label, Randomized 3-Period Crossover Study in Healthy Male Subjects to Evaluate the Pharmacodynamic Interactions Between YM150 on Naproxen at Steady-State
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Apr 2013
Price :
$35
*
At a glance
- Drugs Darexaban (Primary) ; Naproxen (Primary)
- Indications Pain; Rheumatic disorders; Thrombosis
- Focus Pharmacodynamics
- Sponsors Astellas Pharma
- 09 Aug 2011 New trial record